Any alicyclic ketone that consists of a cyclopentane skeleton substituted by at least one oxo group.
ChEBI ID: 36140
Member | Definition | Role |
---|---|---|
16,16-dimethylprostaglandin e2 | A prostanoid that is prostaglandin E2 in which both of the hydrogens at position 16 have been replaced by methyl groups. A synthetic analogue of prostaglandin E2, it is a potent inhibitor of pancreatic function and growth of experimental tumors. It also protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. | 16,16-dimethylprostaglandin E2 |
3-methylcyclopentanone | 3-methylcyclopentanone | |
cyclopentanone | A cyclic ketone that consists of cyclopentane bearing a single oxo substituent. | cyclopentanone |
loxoprofen | A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration. | loxoprofen |
tuberonic acid | An oxo monocarboxylic acid that is (+)-7-isojasmonic acid in which one of the hydrogens of the side-chain methyl group is replaced by a hydroxy group. | tuberonic acid |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 347 (38.01) | 18.7374 |
1990's | 168 (18.40) | 18.2507 |
2000's | 151 (16.54) | 29.6817 |
2010's | 195 (21.36) | 24.3611 |
2020's | 52 (5.70) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 63 (6.65%) | 5.53% |
Reviews | 14 (1.48%) | 6.00% |
Case Studies | 54 (5.70%) | 4.05% |
Observational | 2 (0.21%) | 0.25% |
Other | 814 (85.96%) | 84.16% |